Cited by 12Malaria Research and ControlGlobal Maternal and Child HealthHIV/AIDS Research and Interventions

A comprehensive approach to optimizing malaria prevention in pregnant women: evaluating the efficacy, cost-effectiveness, and resistance of IPTp-SP and IPTp-DP

Open access
Eisenberg, Sarah-Leah, Krieger, Adam E.·2023·Global Health Action

Abstract

Malaria during pregnancy is a major global health concern, with approximately 10,000 pregnant women dying from malaria-related anaemia each year. The World Health Organization has suggested intermittent preventive treatment with sulphadoxine-pyrimethamine (IPTp-SP) to avert malaria infection in pregnant women in malaria-endemic areas, but this intermittent preventive (IP) treatment is at risk of becoming ineffective due to parasite resistance and the contraindication in HIV-infected women. This paper argues that alternative IP treatments such as dihydroartemisinin-piperaquine (DP) should be explored, alongside the urgent need to investigate antimalarial cycling strategies. Additionally, the cost-effectiveness of IPTp-DP should be evaluated, as well as potential barriers to IP treatment such as medication stockouts, late attendance at antenatal clinics, lack of autonomy and freedom among women, and lack of knowledge about malaria prevention. Health education focusing on malaria prevention should be incorporated into routine antenatal care programmes to improve patient compliance. A comprehensive approach that includes the administration of IPTp-DP alone along with other measures such as insecticide-treated nets and medical education is the key to addressing the devastating effects of malaria infection in pregnant women.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1080/16549716.2023.2231257

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Some countries are exploring alternative drugs or combination therapies for IPT.

    “However, some countries are now exploring alternative drugs or combination therapies for IPT [209–211].”

    From Current update on malaria in pregnancy: a systematic review (2025) · cites this paper as [210]

    The Introduction’s ‘Advantages and disadvantages of IPTp-SP and IPTp-DP’ section identifies DP as a potential alternative for IPT in pregnant women, and the ‘Antimalarial cycling strategy’ section considers rotating DP and SP. But the paper proposes exploring these approaches; the cited passages do not establish that some countries are now doing so. Its example of Malawi describes a switch made in 1993, not current exploration. (LLM, conf=0.83)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Eisenberg, S.-L., & Krieger, A. E.
Affiliations
  • Technion – Israel Institute of Technology (IL)
  • University of Southern California (US)
Corresponding author
Eisenberg, Sarah-Leah
Venue
Global Health Action
Published
2023-07-17
Volume
16
Issue
1
Pages
2231257-2231257
ISSN
  • 1654-9716 (ISSN-L)
  • 1654-9880
OpenAlex
W4384498981
Cited by
12
References
20
Citations by year
2026: 4 · 2025: 4 · 2024: 4
FWCI
3.06
Type
journal article
Language
en
Open access
Locations
  • Global Health Action (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
no funding
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Global Maternal and Child Health
  • Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
Keywords
malaria in pregnancy, intermittent preventive treatment, sulfadoxine-pyrimethamine, dihydroartemisinin-piperaquine, antimalarial drug resistance, cost-effectiveness, prenatal care, health education, insecticide-treated nets, medication stockouts, medication adherence, anemia in pregnancy
MeSH terms
Antimalarials, Cost-Benefit Analysis, Drug Combinations, Female, Humans, Malaria, Piperazines, Pregnancy, Pyrimethamine, Quinolines, Sulfadoxine, Artemisinins, Pregnant People

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review